FlowTriever All-Comer Registry for Patient Safety and Hemodynamics

NCT ID: NCT03761173

Last Updated: 2025-10-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-15

Study Completion Date

2024-09-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism (PE). The use of the device will be assessed in a real-world population, with eligibility criteria that closely approximate its use in clinical practice.

Up to 300 additional patients with anticoagulation treatment as the initial planned primary treatment strategy for intermediate risk PE will also be evaluated (US only).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PE - Pulmonary Embolism PE - Pulmonary Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FlowTriever

Mechanical thrombectomy for pulmonary embolism

FlowTriever System

Intervention Type DEVICE

Thrombectomy

Conservative Therapy Sub-Study

Anticoagulation medication for pulmonary embolism (as directed by treating physician)

Anticoagulation Agents

Intervention Type DRUG

Anticoagulation medication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FlowTriever System

Thrombectomy

Intervention Type DEVICE

Anticoagulation Agents

Anticoagulation medication

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical signs and symptoms consistent with acute PE
* Echo, CTPA or pulmonary angiographic evidence of proximal filling defect in at least one main or lobar pulmonary artery
* Scheduled for PE treatment with the FlowTriever System per the Investigator's discretion\*

Exclusion Criteria

* Unable to be anticoagulated with heparin or alternative
* Diagnosis with a minor PE with a less than 0.9 RV/LV ratio
* Known sensitivity to radiographic contrast agents that, in the Investigator's opinion, cannot be adequately pre-treated\*
* Imaging evidence or other evidence that suggests, in the Investigator's opinion, the subject is not appropriate for mechanical thrombectomy intervention\*
* Life expectancy \< 30 days, as determined by Investigator
* Current participation in another investigational drug or device treatment study that, in the Investigator's opinion, would interfere with participation in this study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inari Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Catalin Toma, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UAB Division of Cardiovascular Disease

Birmingham, Alabama, United States

Site Status

University of Arizona College of Medicine

Tucson, Arizona, United States

Site Status

Pima Heart and Vascular

Tucson, Arizona, United States

Site Status

University of Colorado

Aurora, Colorado, United States

Site Status

Yale University

New Haven, Connecticut, United States

Site Status

Christiana Care Health Services

Newark, Delaware, United States

Site Status

Memorial Hospital Jacksonville

Jacksonville, Florida, United States

Site Status

Lakeland Vascular Institute

Lakeland, Florida, United States

Site Status

Palmetto General Hospital

Miami, Florida, United States

Site Status

University of Miami

Miami, Florida, United States

Site Status

Mount Sinai Medical Center of Florida

Miami, Florida, United States

Site Status

Ascension Sacred Heart

Pensacola, Florida, United States

Site Status

Sarasota Memorial Hospital

Sarasota, Florida, United States

Site Status

Tallahassee Memorial Hospital

Tallahassee, Florida, United States

Site Status

Emory University

Atlanta, Georgia, United States

Site Status

Rush Medical Center

Chicago, Illinois, United States

Site Status

University of Chicago

Chicago, Illinois, United States

Site Status

Northwestern University

Evanston, Illinois, United States

Site Status

Javon Bea Hospital

Rockford, Illinois, United States

Site Status

Indiana University School of Medicine

Indianapolis, Indiana, United States

Site Status

Norton Healthcare

Louisville, Kentucky, United States

Site Status

Baptist Health Lousville

Louisville, Kentucky, United States

Site Status

Opelousas General

Opelousas, Louisiana, United States

Site Status

Henry Ford Health System

Detroit, Michigan, United States

Site Status

Ascension Genesys Hospital

Grand Blanc, Michigan, United States

Site Status

Ascension Providence Hospital

Madison Heights, Michigan, United States

Site Status

Ascension Providence Rochester Hospital

Rochester, Michigan, United States

Site Status

Beaumont Health

Royal Oak, Michigan, United States

Site Status

St. Joseph Mercy

Ypsilanti, Michigan, United States

Site Status

Metropolitan Heart and Vascular Institute

Minneapolis, Minnesota, United States

Site Status

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

CentraCare Heart & Vascular Center

Saint Cloud, Minnesota, United States

Site Status

Missouri Cardiovascular Specialists

Columbia, Missouri, United States

Site Status

University of Missouri, Columbia

Columbia, Missouri, United States

Site Status

Saint Luke's Hospital of Kansas City

Lee's Summit, Missouri, United States

Site Status

Valley Health

Ridgewood, New Jersey, United States

Site Status

Albany Medical Center

Albany, New York, United States

Site Status

SUNY, The University at Buffalo

Buffalo, New York, United States

Site Status

Northwell Health

Manhasset, New York, United States

Site Status

NYU Langone Medical Center

New York, New York, United States

Site Status

Mount Sinai

New York, New York, United States

Site Status

Jamaica Hospital

Queens, New York, United States

Site Status

St. Francis Hospital & Heart Center

Roslyn, New York, United States

Site Status

Westchester Medical Center

Valhalla, New York, United States

Site Status

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, United States

Site Status

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Site Status

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Site Status

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

Lexington Medical Center

West Columbia, South Carolina, United States

Site Status

Methodist Healthcare Foundation

Germantown, Tennessee, United States

Site Status

UTMC Knoxville

Knoxville, Tennessee, United States

Site Status

St. Thomas West

Nashville, Tennessee, United States

Site Status

CardioVoyage

Denison, Texas, United States

Site Status

Inova Fairfax

Falls Church, Virginia, United States

Site Status

Sentara

Norfolk, Virginia, United States

Site Status

Providence Regional Medical Center Everett

Everett, Washington, United States

Site Status

Providence Sacred Heart

Spokane, Washington, United States

Site Status

Aurora St. Luke's Medical Center

Milwaukee, Wisconsin, United States

Site Status

Allgemeines Krankenhaus AKH Wien

Vienna, , Austria

Site Status

UZ Antwerpen

Antwerp, , Belgium

Site Status

UZ Brussel

Brussels, , Belgium

Site Status

Centre Hospitalier Universitaire de Besançon

Besançon, , France

Site Status

Hopital de la Cavale Blanche - CHU Brest

Brest, , France

Site Status

CHU Grenoble

Grenoble, , France

Site Status

Institut Coeur Poumon - CHU de Lille

Lille, , France

Site Status

HCL Hôpital Louis Pradel - Hôpital Cardiologique

Lyon, , France

Site Status

European Hospital Georges Pompidou

Paris, , France

Site Status

Charité Hospital - Campus Virchow-Klinikum

Berlin, , Germany

Site Status

Cardioangiologisches Centrum Bethanien

Frankfurt, , Germany

Site Status

University Hospital

Heidelberg, , Germany

Site Status

Universitatsklinikum des Saarlandes

Homburg, , Germany

Site Status

Helios Kliniken Schwerin

Schwerin, , Germany

Site Status

Universitair Medisch Centrum Utrecht

Utrecht, , Netherlands

Site Status

Hospital Clínico San Carlos

Madrid, , Spain

Site Status

Gregorio Maranon University Hospital

Madrid, , Spain

Site Status

Inselspital

Bern, , Switzerland

Site Status

Kantonsspital Sankt Gallen

Sankt Gallen, , Switzerland

Site Status

Unispital

Zurich, , Switzerland

Site Status

The Royal Free Hospital

London, , United Kingdom

Site Status

The Royal London Hospital, Bart's Health

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Belgium France Germany Netherlands Spain Switzerland United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Horowitz JM, Jaber WA, Stegman B, Rosenberg M, Fanola C, Bhat AP, Gondi S, Castle J, Ahmed M, Brown MA, Amin R, Bisharat M, Butros P, DuCoffe A, Savin M, Pollak JS, Weinberg MD, Brancheau D, Toma C. Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry. J Soc Cardiovasc Angiogr Interv. 2023 Oct 31;3(1):101124. doi: 10.1016/j.jscai.2023.101124. eCollection 2024 Jan.

Reference Type BACKGROUND
PMID: 39131977 (View on PubMed)

Khandhar S, Jaber W, Bunte MC, Cho K, Weinberg MD, Mina B, Stegman B, Pollak J, Khosla A, Elmasri F, Zlotnick D, Brancheau D, Koenig G, Bisharat M, Li J, Toma C. Longer-Term Outcomes Following Mechanical Thrombectomy for Intermediate- and High-Risk Pulmonary Embolism: 6-Month FLASH Registry Results. J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):101000. doi: 10.1016/j.jscai.2023.101000. eCollection 2023 Jul-Aug.

Reference Type BACKGROUND
PMID: 39131661 (View on PubMed)

Bangalore S, Horowitz JM, Beam D, Jaber WA, Khandhar S, Toma C, Weinberg MD, Mina B. Prevalence and Predictors of Cardiogenic Shock in Intermediate-Risk Pulmonary Embolism: Insights From the FLASH Registry. JACC Cardiovasc Interv. 2023 Apr 24;16(8):958-972. doi: 10.1016/j.jcin.2023.02.004.

Reference Type BACKGROUND
PMID: 37100559 (View on PubMed)

Toma C, Jaber WA, Weinberg MD, Bunte MC, Khandhar S, Stegman B, Gondi S, Chambers J, Amin R, Leung DA, Kado H, Brown MA, Sarosi MG, Bhat AP, Castle J, Savin M, Siskin G, Rosenberg M, Fanola C, Horowitz JM, Pollak JS. Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism. EuroIntervention. 2023 Feb 20;18(14):1201-1212. doi: 10.4244/EIJ-D-22-00732.

Reference Type BACKGROUND
PMID: 36349702 (View on PubMed)

Toma C, Bunte MC, Cho KH, Jaber WA, Chambers J, Stegman B, Gondi S, Leung DA, Savin M, Khandhar S, Kado H, Koenig G, Weinberg M, Beasley RE, Roberts J, Angel W, Sarosi MG, Qaqi O, Veerina K, Brown MA, Pollak JS. Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry. Catheter Cardiovasc Interv. 2022 Mar;99(4):1345-1355. doi: 10.1002/ccd.30091. Epub 2022 Feb 3.

Reference Type BACKGROUND
PMID: 35114059 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The PEERLESS II Study
NCT06055920 RECRUITING NA
Mechanical Thrombectomy for Acute Pulmonary Embolism
NCT07032025 NOT_YET_RECRUITING EARLY_PHASE1
Epoprostenol in Pulmonary Embolism
NCT01014156 COMPLETED PHASE4